![Alise Reicin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alise Reicin
Direktor/Vorstandsmitglied bei SANA BIOTECHNOLOGY, INC.
Vermögen: - $ am 31.05.2024
Profil
Dr. Alise S.
Reicin, MD, is a Chief Executive Officer & Director at Avrobio, Inc., an Independent Director at Sana Biotechnology, Inc., a President, Chief Executive Officer & Director at Tectonic Therapeutic, Inc. and a Venture Advisor at Israel Biotech Fund.
She is on the Board of Directors at Avrobio, Inc., Sana Biotechnology, Inc., Tectonic Therapeutic, Inc. and Sharsheret, Inc. Dr. Reicin was previously employed as an Independent Director by Homology Medicines, Inc., a President-Global Clinical Development by Celgene Corp., a Head-Global Clinical Development by EMD Serono, Inc., a Member by Columbia University Vagelos College of Physicians & Surgeons, and a VP-Oncology Program & Pipeline Leadership by Merck & Co., Inc. She received her undergraduate degree from Barnard College and a doctorate degree from Harvard Medical School.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
-.--% | 14.06.2023 | 0 ( -.--% ) | - $ | 31.05.2024 |
SANA BIOTECHNOLOGY, INC.
-.--% | 06.06.2024 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Alise Reicin
Unternehmen | Position | Beginn |
---|---|---|
SANA BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 01.12.2020 |
Tectonic Therapeutic, Inc.
![]() Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Tectonic Therapeutic, Inc. is a biotech company based in Watertown, MA. Tectonic is focused on transforming the discovery of antibodies and other biologic drugs targeting G-protein coupled receptors (GPCRs) to develop novel therapies for patients inadequately served by current treatments. The company's proprietary Geode platform aims to unlock the therapeutic utility of the most difficult receptors in the class, which have been considered undruggable with small molecules. The company was founded by Timothy A. Springer and Andrew Kruse of Harvard Medical School. Alise S. Reicin has been the CEO of the company since 2020. | Vorstandsvorsitzender | 01.08.2020 |
Sharsheret, Inc.
![]() Sharsheret, Inc. Miscellaneous Commercial ServicesCommercial Services Sharsheret, Inc. is a leading Jewish cancer organization that provides free support and educational programs for breast cancer survivors. The non-profit company is based in Teaneck, NJ and the CEO of the company is Elana Silber. The company's program, Best Face Forward 2.0, offers services and subsidies for eligible individuals for non-medical services critical to a woman's quality of life. The company also offers support and resources for those who are BRCA+ or have a family history of BRCA. | Direktor/Vorstandsmitglied | - |
Israel Biotech Fund
![]() Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Berater | - |
Ehemalige bekannte Positionen von Alise Reicin
Unternehmen | Position | Ende |
---|---|---|
CELGENE | Corporate Officer/Principal | 01.12.2019 |
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2018 |
TECC THERPAR | Vorstandsvorsitzender | - |
MERCK & CO., INC. | Corporate Officer/Principal | - |
Columbia University Vagelos College of Physicians & Surgeons | Corporate Officer/Principal | - |
Ausbildung von Alise Reicin
Barnard College | Undergraduate Degree |
Harvard Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
SANA BIOTECHNOLOGY, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Celgene Corp.
![]() Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Homology Medicines, Inc.
![]() Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Tectonic Therapeutic, Inc.
![]() Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Tectonic Therapeutic, Inc. is a biotech company based in Watertown, MA. Tectonic is focused on transforming the discovery of antibodies and other biologic drugs targeting G-protein coupled receptors (GPCRs) to develop novel therapies for patients inadequately served by current treatments. The company's proprietary Geode platform aims to unlock the therapeutic utility of the most difficult receptors in the class, which have been considered undruggable with small molecules. The company was founded by Timothy A. Springer and Andrew Kruse of Harvard Medical School. Alise S. Reicin has been the CEO of the company since 2020. | Commercial Services |
Sharsheret, Inc.
![]() Sharsheret, Inc. Miscellaneous Commercial ServicesCommercial Services Sharsheret, Inc. is a leading Jewish cancer organization that provides free support and educational programs for breast cancer survivors. The non-profit company is based in Teaneck, NJ and the CEO of the company is Elana Silber. The company's program, Best Face Forward 2.0, offers services and subsidies for eligible individuals for non-medical services critical to a woman's quality of life. The company also offers support and resources for those who are BRCA+ or have a family history of BRCA. | Commercial Services |
Israel Biotech Fund
![]() Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
Avrobio, Inc.
![]() Avrobio, Inc. BiotechnologyHealth Technology AVROBIO, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Watertown, MA. | Health Technology |